Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.

Fat cells are also metabolically active and can cause a chronic state of inflammation in the part of the body where they ...

The cutting-edge weight-loss drug Ozempic/Wegovy can stop and even reverse fatty liver disease, a new clinical trial has found. Nearly twice as many people taking semaglutide stopped their fatty ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new study published Wednesday.

Fatty liver disease, also called metabolic dysfunction-associated steatohepatitis (MASH), is a condition where fat accumulates in the liver, causing inflammation and scarring. Over time, this damage ...

Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ — 63%, compared with 34% of those taking a placebo, researchers reported ...

A game-changing medication known for diabetes and weight loss might also hold the key to improving liver health for millions of Americans.

The cutting-edge weight-loss drug Ozempic/Wegovy can stop and even reverse fatty liver disease, a new clinical trial has found. Nearly twice as many people taking semaglutide stopped their fatty ...

“By treating both liver disease and its metabolic causes, semaglutide offers a promising new approach for millions of patients.” The clinical trial involved participants with moderate to ...

One study found that semaglutide helps to improve liver health in people with metabolic dysfunction-associated steatohepatitis, a serious form of fatty liver disease. The use of semaglutide ...

People on the drug had less liver inflammation and scarring They also lost weight and had better liver function THURSDAY, May 1, 2025 (HealthDay News) -- The cutting-edge weight-loss drug Ozempic ...